JNJ-31020028

Anti-Anxiety Agent; structure in first source

Also Known As:

JNJ31020028; N-(4-(4-(2-(diethylamino)-2-oxo-1-phenylethyl)piperazin-1-yl)-3-fluorophenyl)-2-pyridin-3-ylbenzamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Vomiting 05/01/2013 - "Pretreatment with the neuropeptide Y2 receptor antagonist JNJ-31020028 attenuated DON- and PYY-induced emesis, whereas the CCK1 receptor antagonist devezapide did not alter DON's emetic effects. "